Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Trading Statement

13 Apr 2011 07:00

RNS Number : 7990E
Flying Brands Limited
13 April 2011
Β 

ο»Ώ

13 April 2011

Β 

FLYING BRANDS LIMITED

Β 

Trading Update

Β 

Since our preliminary results announcement the business has continued to operate against the backdrop of an increasingly challenging consumer environment and increasing competition in its key markets. Overall Group orders for the period to 1 April 2011 of Β£10.8m (Β£2010: Β£10.7m) are marginally ahead of the same period last year. On a like for like basis, excluding those businesses we acquired in 2010, orders are 19.8% below last year.

Β 

Overall we believe that our strategy for transforming our business remains the right one but the continuing under-performance in the traditional flowers business and the recent decline in our bird food business means that profits for this year will be materially below market expectations. We will need to renegotiate the terms of our banking arrangements and we will be commencing discussions with our lenders very shortly.

Β 

Β 

Flowers & Gifts

The performance of our Flowers and Gifts Division over the important first quarter was materially below our expectations in what is currently our main direct-to-consumer (DTC) business. Orders to 1 April 2011 were Β£3.4m (2010: Β£2.3m); this includes first time contributions from Flowers Direct and Drake Algar. Like for like orders were 14.7% below last year. Our DTC businesses have been impacted, like many retailers, by weak consumer confidence. We have also experienced increasing competition from general retailers and more discounting from other specialist flower companies. Mothers Day trading in the three weeks prior to that event was particularly difficult with sales materially below our expectations.

Β 

The performance of the relay network is improving and we expect to conclude at least one large third party deal in the near future.

Β 

We are accelerating our plans to increase the emphasis on our relay network, on retail partnerships and corporate business, which we believe will transform the prospects for our flowers and gifts division.

Β 

In the short-term our new initiatives will not be enough to offset the decline in our traditional DTC business as we transition to this new business model.

Β 

Β 

Garden

Our Garden Division has had a mixed start to the year. Our bird food business has seen very challenging trading conditions with a marked increase in competition from low cost providers such as the supermarkets and garden centres and an increase in the number of entrants to the online market. Orders to 1 April at Β£0.8m are 33.5% down on last year. Profits for the year-to-date are materially below our expectations and we do not expect trading conditions to improve markedly in the short-term.

Β 

Gardening Direct orders at 1 April are Β£5.5m (2010:Β£6.4m).

Β 

The business had a challenging March with sales materially below expectations but April has started well. It remains to be seen whether we can claw back at least some of that under-performance. We reduced our marketing expenditure in off the page advertising during the first quarter to reflect the lower demand but are monitoring the market to make sure we take advantage of any perceived upturn. We do not now expect the financial performance of the business in the first half of the year to be better than last year.

Β 

We recently improved our site at www.gardencentreonline.co.uk and are planning a major re-launch of this brand when these improvements are completed and fully bedded down. Even prior to that re-launch sales are now regularly ahead of last year and we are pleased that this business is trading in line with our expectations in an increasingly challenging consumer environment. We expect www.gardencentreonline.co.uk to be an increasingly important part of our business in future.

Β 

Β 

Dealtastic

Our new Dealtastic site is still in its early stages. The functionality and features on this "deal of the day" site continue to improve from week to week and we are starting to see increased traffic to that site although we have not yet seen a significant increase in weekly sales.

Β 

Β 

For further information, please contact:

Β 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Anthony Gee, Finance Director

Β 

SmithfieldΒ Consultants 020 7360 4900John Kiely

Β 

Notes to editors

Β 

JerseyΒ based Flying Brands Limited (LSE: FBDU) is a multi brandΒ and multi channelΒ home shopping specialist. Founded in 1981, it was admitted to the Official List of the London Stock Exchange in 1993. The Group operates the following divisions:Β 

Β 

Β·; GiftsΒ (Flying Flowers, Flowers Direct and Drake AlgarΒ  making the company one of the UK'sleading florists)

Β·; GardenΒ (Gardening Direct, one of theΒ UK's largest mail order bedding plants and gardening products operations;Β Garden Bird Supplies, a leading provider of food and accessories for birds and other wildlife; Garden Centre Online, an internet retailer of garden hardware products)

Β·; EntertainmentΒ (Listen2,Β a mail order audio books,Β nostalgic music,Β DVD and video home shopping retailer)

Β·; Dealtastic (Deal a day website)

More information can be found at:Β www.flyingbrands.com

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTLLFVDSIIFLIL
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.